Literature DB >> 1783061

Mycobacterium xenopi isolation from clinical specimens in the Florence area: review of 46 cases.

E Tortoli1, M T Simonetti, C Labardi, A Lopes Pegna, E Meli, N Stanflin, S Susini.   

Abstract

The occurrence of Mycobacterium xenopi (MX) isolates is not homogeneous in various geographic zones. In the Florence area, between 1975-1989, strains of MX from 64 different patients have been isolated. The review of bacteriological and clinical data of 46 of them, from whose sputum MX had been grown, allowed to diagnose for 26% the commensal nature of this finding, for 41% the concomitance with a tubercular infection and for the remaining 33% the pathogenicity of this microorganism. The increased occurrence of MX isolates, their high rate of pathogenicity and the remarkable homogeneity of their biochemical, cultural and antimicrobial sensitivity patterns seem to suggest the hypothesis of an endemic focus of this species in the Florence area.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1783061     DOI: 10.1007/bf00218681

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  30 in total

1.  A strain of Mycobacterium isolated from skin lesions of a cold-blooded animal, Xenopus laevis, and its relation to atypical acid-fast bacilli occurring in man.

Authors:  H SCHWABACHER
Journal:  J Hyg (Lond)       Date:  1959-03

Review 2.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

3.  Mycobacterium xenopi, pathogen of the future?

Authors:  A F Rahman; A L Sinclair
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

4.  Disseminated Mycobacterium xenopi infection.

Authors:  J R Weinberg; G Dootson; D Gertner; S T Chambers; H Smith
Journal:  Lancet       Date:  1985-05-04       Impact factor: 79.321

5.  Diagnostic probability matrix for identification of slowly growing mycobacteria in clinical laboratories.

Authors:  L G Wayne; M I Krichevsky; D Portyrata; C K Jackson
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

6.  Lung infection due to Mycobacterium xenopi: report of the first case in Japan.

Authors:  M Tsukamura; K Sekine; A Yokota; A Kuze; M Shibata; K Sato
Journal:  Microbiol Immunol       Date:  1984       Impact factor: 1.955

7.  The isolation of M. kansasii and M. xenopi from water systems.

Authors:  D A McSwiggan; C H Collins
Journal:  Tubercle       Date:  1974-12

8.  The role of Mycobacterium xenopi in human disease.

Authors:  A E Simor; I E Salit; H Vellend
Journal:  Am Rev Respir Dis       Date:  1984-03

9.  Water-borne Mycobacterium xenopi--a possible cause of pulmonary mycobacteriosis in man.

Authors:  Z Horák; H Poláková; M Králová
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1986

10.  [Mycobacterium xenopei (Marks and Schwabacher, 1965), a scotochromogenic, thermophilic, dysgonic mycobacterium, possibly pathogenic for man].

Authors:  H Boisvert
Journal:  Ann Inst Pasteur (Paris)       Date:  1965-09
View more
  2 in total

1.  Nasal Mycobacterium kansasii infection in a patient with acquired immunodeficiency syndrome.

Authors:  E Tortoli; M T Simonetti; D Dionisio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-07       Impact factor: 3.267

2.  DNA fingerprinting of Mycobacterium bovis strains by restriction fragment analysis and hybridization with insertion elements IS1081 and IS6110.

Authors:  D M Collins; S K Erasmuson; D M Stephens; G F Yates; G W De Lisle
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.